Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2010 Feb;95(2):175-8.
doi: 10.3324/haematol.2009.017046.

Pathogenesis and treatment of anemia in inflammatory bowel disease

Editorial

Pathogenesis and treatment of anemia in inflammatory bowel disease

Günter Weiss et al. Haematologica. 2010 Feb.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Pathophysiological mechanisms contributing to anemia in patients with IBD. Cytokines induce the formation of hepcidin which then blocks cellular iron (Fe2+) export via ferroportin (FPN) from macrophages and inhibits the transfer of absorbed iron from enterocytes to the circulation. This results in a reduction of circulating iron and limited availability of the metal for erythroid progenitors, thus blocking erythropoiesis. Cytokines, such as tumor necrosis factor (TNF)-agr; and interferon (IFN)-γ, also aggravate iron restriction in macrophages by stimulating iron uptake and promoting erythrophagocytosis while inhibiting iron export via repression of ferroportin transcription. In addition, TNF-α further contributes to blockage of iron absorption. Iron deficiency can also be aggravated by chronic blood loss from intestinal lesions caused by active IBD. Erythropoiesis is further impaired as a consequence of a cytokine-mediated reduction of the formation and/or the biological activity of erythropoeitin (Epo) along with direct anti-proliferative effects of these cytokines on erythroid progenitor cells. Finally, vitamin deficiencies can impair erythroid differentiation.

Comment on

References

    1. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011–23. - PubMed
    1. Gomollon F, Gisbert JP. Anemia and inflammatory bowel diseases. World J Gastroenterol. 2009;15(37):4659–65. - PMC - PubMed
    1. Gasche C, Lomer MC, Cavill I, Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut. 2004;53(8):1190–7. - PMC - PubMed
    1. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090–3. - PubMed
    1. Johnson D, Babele H, Johnston K, Tennant J, Srai SK, Sharp P. Tumour necrosis factor alpha regulates iron transport and transporter expression in human intestinal epithelial cells. FEBS Lett. 2004;573(1–3):195–201. - PubMed